Overcoming bio/pharmaceutical production hurdles: an industry insider perspective
From F-gas regulation to finance and from biologics to personalised medicines, the global drug production
environment faces a number of challenges that could potentially stifle innovation and profitability. Dr Kevin
Robinson (KSR) recently spoke to key players in the supplier and outsourcing community to better understand what
services and solutions are available to keep the pipeline flowing.
Read more
From F-gas regulation to finance and from biologics to personalised medicines, the global drug production
environment faces a number of challenges that could potentially stifle innovation and profitability. Dr Kevin
Robinson (KSR) recently spoke to key players in the supplier and outsourcing community to better understand what
services and solutions are available to keep the pipeline flowing.
Read more
Share article
Related Content